NRIX nurixtx.com Net earnings per share growth forecast for next year

Corporate company logo of Nurix Corp (NRIX)

Nurix Therapeutics specializes in developing targeted oncology drugs, monetizing deep research into disease mechanisms. The projected earnings per share for the coming year reflects market expectations, where the value -180.90 serves as the target level. While the company implements ESG standards within its laboratories, high R&D expenditures and early-stage trial risks create certain volatility.

NRIX: Nurix Therapeutics Inc Net earnings per one share growth forecast for next year 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for Nurix Therapeutics, Inc. (NRIX)

- share price and consensus valuation forecast:
Fundamental company analysis:Nurix Therapeutics, Inc., NRIX
Brand item of nurixtx.com

For PROTAC technology innovator Nurix Therapeutics (NRIX), the consensus EPS forecast for the coming year with a value of -180.90 reflects aggregated expert expectations for net income dynamics. This metric measures the shift in market valuations regarding R&D spending efficiency, where an upward trend on the chart signals capitalization potential while simultaneously increasing price volatility upon any deviation from projected figures.

Competing companies

GMAB (Genmab Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year exelixis.com|Net earnings per share growth forecast for next year Nuvalent (NUVL)|KYMR (Kymera) - Expected earnings per share trend next year|Earnings growth forecast for next year IDYA (IDEAYA Biosciences Inc)|Net earnings per one share growth forecast for next year Enliven Pharma|ORIC Pharmaceuticals Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Relay Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Expected earnings per share growth for next year|VSTM: Projected earnings per share increase next year|GLUE (monterosatx.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year Cullinan Therapeutics Inc CGEM|Earnings growth forecast for next year IMRX|C4 Therapeutics - Projected earnings per share growth rate for next year|Black Diamond Therapeutics - Expected earnings per share growth for next year|Expected earnings per share trend next year RPTX|PMVP: Expected earnings per share growth for next year|karyopharm.com - Projected earnings per share increase next year|PPCB: Earnings growth forecast for next year|Bio Green Med Solution Inc - Expected earnings per share trend next year|AADI (Aadi Bioscience Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year aileronrx.com ALRN|Net earnings per share growth forecast for next year Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks Therapeutics, Inc)